Skip to content

GE HealthCare Technologies GEHC Imaging — Acquisitions

Other segment segments

AVS
$0
PCS
$0
PDx
$0-100%

Similar metrics at other companies

Teledyne Technologies logo
TDYDigital Imaging — Current year acquisitions
$0
Dover logo
DOVImaging & Identification — Capital expenditures:
$9.48M-1.8%
Stewart Information Services logo
STCCorporate — Acquisitions
$0
TIC Solutions
 logo
TICInspection and Mitigation — Acquisitions
$0
Hillman Solutions Corp. logo
HLMNRobotics and Digital Solutions — Acquisitions
$0
ABM Industries logo
ABMTechnical Solutions — Acquisitions
$3.68M-81.8%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.91B-9.2%
P/E15.7×+1.0×
P/S1.4×-0.2×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's imaging — acquisitions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's imaging — acquisitions?
GE HealthCare Technologies (GEHC) reported imaging — acquisitions of $1.58B in Q1 2026.
What does imaging — acquisitions mean?
The total capital deployed by the Imaging segment to acquire other companies, technologies, or product lines. This metric tracks the segment's inorganic growth strategy and its commitment to expanding its product portfolio or technological capabilities. It is a key indicator of how the company is investing to maintain its competitive edge in the imaging market.